While genome‐wide association studies as well as candidate gene studies have revealed a
great deal of insight into the contribution of genetics to obesity development and …

We have reviewed the effects of angiotensin II type 1 receptor antagonists (ARBs) in various
animal models of hypertension, atherosclerosis, cardiac function, hypertrophy and fibrosis …

The mechanisms for the development of diabetic cardiomyopathy remain largely unknown.
Methylglyoxal (MG) can accumulate and promote inflammation and vascular damage in …

We test whether plasma level of methylglyoxal (MG) is an independent risk factor predicting
the progression of diabetic macroangiopathy or microangiopathy in type 2 diabetic patients …

Methylglyoxal (MGO), an active metabolite of glucose, can cause cellular injury which has
an affinity for the progression of diabetes-associated atherosclerosis. Phosphocreatine (PCr) …

Methylglyoxal (MGO) is a reactive metabolite of glucose. Since the plasma concentration of
MGO is increased in diabetic patients, MGO is implicated in diabetes-associated vascular …

Aim Vaspin (visceral adipose tissue‐derived serine protease inhibitor) is a novel
adipocytokine found in visceral white adipose tissues of obese type 2 diabetic rats. We have …

Methylglyoxal (MGO) is a highly reactive dicarbonyl compound known to induce cellular
injury and cytoxicity, including apoptosis in vascular cells. Vascular endothelial cell …

Although methylglyoxal (MGO) has emerged as key mediator of diabetic microvascular
complications, the influence of MGO on the vascular transcriptome has not thoroughly been …

We investigated the protective effect of telmisartan, an angiotensin II receptor antagonist,
against ischemia/reperfusion renal injury in rats. Bilateral ischemia was induced by …